Cyclin dependent kinases are regulated by phosphorylation and dephosphorylation of the catalytic cdk subunits, by assembly with specific cyclins and by specific inhibitor molecules. Recently, it turned out that cyclins are also phosphoproteins, which means that they are also potential targets for a regulation by phosphorylation and dephosphorylation. Here, we show that cyclin H was phosphorylated by protein kinase CK2. Like most other CK2 substrates cyclin H was much better phosphorylated by the CK2 holoenzyme than by the a-subunit alone. By using point mutants derived from the cyclin H sequence we mapped the CK2 phosphorylation site at threonine 315 at the C-terminal end of cyclin H. Phosphorylation at this position had no influence on the assembly of the cyclin H/cdk7/Mat1 complex. However, phosphorylation at amino acid 315 of cyclin H turned out to be critical for a full cyclin H/cdk7/Mat1 kinase activity when the CTD peptide of RNA polymerase II or cdk2 was used as a substrate.
Introduction
Cell cycle progression is tightly regulated by cyclin dependent kinases (cdks). The activity of these kinases is controlled by phosphorylation and dephosphorylation events, by binding of the regulatory subunits, namely the cyclins to the catalytic cdk-subunits, as well as by the interaction of inhibitor molecules with the cyclin/cdk-complexes (Kaldis, 1999) . Cyclin dependent kinases are phosphorylated on several sites including two inhibitory and one activating site. The inhibitory phosphorylation sites on human cdc2, Thr-14 and Tyr-15, keep the p34 cdc2 kinase silent until dephosphorylation by cdc25C activates p34 cdc2 , which goes along with an initiation of mitosis. A third phosphorylation at Thr-160 is also essential for the activity of p34 cdc2 and this phosphorylation is achieved by another cyclin dependent kinase complex which is known as cdk activating kinase CAK. This kinase complex consists of three subunits: the regulatory subunit cyclin H, the catalytic subunit cdk7 and a third protein factor, named Mat1. This third factor, which is unusual for other cdk/cyclin-complexes is an assembly factor for the cyclin H/cdk7/Mat1 complex (Johnson and Walker, 1999) and seems to be implicated in the regulation of substrate specificity.
In contrast to other cyclin dependent kinases levels of cyclin H, cdk7 and Mat1 subunits as well as the resulting kinase activity do not greatly vary over the eukaryotic cell cycle (Adamczewski et al., 1996; Morgan, 1994, Fisher et al, 1995) . The cyclin H/cdk7/ Mat1 complex is found either in a free state (Morgan, 1995) or as a part of the transcription factor complex TFIIH (Svejstrup et al., 1996) . This TFIIH complex has a central role in two processes: first as a basal factor in the regulation of the transcription of RNA polymerase II and second as an essential component of the DNA repair complex which is responsible for the nucleotide excision repair (Schaefer et al., 1993) . Two classes of substrates for the cyclin H/cdk7/Mat1 complexes are known, namely downstream cyclin dependent kinases as well as components of the transcription machinery of the cell including the C-terminal domain (CTD) of the large subunit of RNA polymerase II (Feaver et al., 1994) and the growth suppressor protein p53 (Ko et al., 1997; Lu et al., 1997) . Human cyclin H is a polypeptide of 323 amino acids with a molecular weight of 38 kDa. When cyclin H assembles with cdk7 the kinase is activated and the activity is further enhanced by the third factor Mat1. So far, only little is known about the regulation of cyclin H/cdk7/Mat1 activity.
We have recently shown that wild-type p53 binds to cyclin H and this binding leads to a down-regulation of the kinase activity in vitro and in vivo (Schneider et al., 1998) . p53 is a growth suppressor and a regulator of cell cycle progression. Upon DNA damage and after reduction of the nucleotide pool p53 transactivates a number of different genes including the p21 WAF1 gene. Elevated transcription of the p21 WAF1 leads to an increase in the concentration of the p21 WAF1 protein which is an efficient inhibitor of cyclin dependent kinases (El-Deiry et al., 1993). Thus, p53 regulates cyclin dependent kinases indirectly by transactivating an inhibitor molecule for these kinases. An alternative way to explain a p53 dependent cell cycle arrest independent of p21 might exist in form of the observed p53/CAK interaction.
Recently, it was shown that cyclin H is a phosphoprotein and one of the kinases that phosphorylate cyclin H was identified as cyclin C/cdk8. This enzyme phosphorylates cyclin H at residues Ser-5 and Ser-304 both in vitro and in vivo (Akoulitchev et al., 2000) . These two phosphorylation sites are in the vicinity of N-and C-terminal helices which are uniquely orientated in cyclin H as compared with other cyclins (Andersen et al., 1997) . Phosphorylation of cyclin H in the TFIIH complex results in inhibition of its transcription activity whereas when Ser-5 and Ser-304 were substituted by alanine transcription was not inhibited. Here, we show that cyclin H is a substrate for another protein kinase namely protein kinase CK2. Furthermore, we identified the phosphorylation site for CK2 at position 315 on the polypeptide chain of cyclin H and analysed the influence of this phosphorylation on the activity of the cyclin H/cdk7/ Mat1 complex. Using point mutants of cyclin H (T315D and T315A) mimicking phosphorylated or unphosphorylated cyclin H, respectively, we analysed the kinase activity of the cyclin H/cdk7/Mat1 complex. Based on these data we concluded that the phosphorylation of cyclin H at Thr-315 by CK2 seems to be necessary for full kinase activity of the cyclin H/cdk7/ Mat1 complex with respect to the phosphorylation of the CTD peptide derived from the C-terminal domain of RNA polymerase II as well as the phosphorylation of cdk2.
Results
Human cyclin H is a phosphoprotein of 323 amino acids with a molecular weight of 38 kDa. Analysis of the primary sequence of cyclin H revealed the existence of several potential phosphorylation sites for protein kinase CK2. Protein kinase CK2 is a holoenzyme composed of two regulatory b-subunits and two catalytic a-or a'-subunits. Most of the CK2 substrates are efficiently phosphorylated only by the CK2 holoenzyme whereas a few substrates are phosphorylated by the catalytic a-subunit alone (for review see: Guerra and Issinger, 1999b) . Therefore, we first analysed whether cyclin H is in vitro a substrate of CK2 and second whether cyclin H is phoshorylated by the a-subunit alone or by the holoenzyme composed of a-and b-subunits. Bacterially expressed recombinant cyclin H was purified and then incubated with the asubunit and [g-32 P]ATP or with the holoenzyme and [g-32 P]ATP in the absence or presence of heparin, an efficient inhibitor of CK2 kinase activity (Hathaway et al., 1980) . Phosphorylated products were analysed by SDS polyacrylamide gel electrophoresis of the whole reaction mixture and autoradiography. Figure 1b shows a Coomassie blue stained gel which demonstrates the amount of cyclin H which was present in each lane of Figure 1a . As shown in Figure 1a (lane 1) cyclin H was efficiently phosphorylated by the CK2 holoenzyme and weaker phosphorylated by the CK2 asubunit alone (lane 3). Phosphorylation of cyclin H by the CK2 holoenzyme as well as the CK2 a-subunit was inhibited by heparin (lanes 2 and 4). This shows that cyclin H is in fact a substrate of CK2 and behaves very similar to the majority of other CK2 substrates. Lanes 5 and 6 are controls where cyclin H was incubated with [g-32 P]ATP in the absence of added CK2 in order to demonstrate the absence of a protein kinase in the cyclin H preparation. As a control for the correct separation of cyclin H by SDS polyacrylamide gel electrophoresis we used bacterially expressed recombinant cyclin H which was phosphorylated with protein kinase A (heart muscle kinase, Sigma) within an artificial PKA-site at the N-terminus of the cyclin H (lane 7).
By scanning the polypeptide chain of cyclin H for potential phosphorylation sites five different sequences were found as putative CK2 phosphorylation sites (marked by P in Figure 2 ). Taking into consideration the consensus sequence for CK2 phosphorylation and the fact that the presence of additional Asp or Glu residues at positions 73,+1,+2,+4,+5 or +7 relative to the Ser or Thr residues which are phosphorylated improves phosphorylation efficacy Meggio et al., 1994) all points to T 315 as the preferred target site for phosphorylation. Threonine 315 is exceptional out of the five putative CK2 sites because it is immersed within an acidic In order to map the phosphorylation of cyclin H directly to threonine 315 we constructed two point mutants of cyclin H where amino acid threonine 315 was substituted by alanine (T315A) or by aspartic acid (T315D). These two mutants as well as full-length cyclin H were expressed in baculovirus infected Sf9 cells, purified and then equal amounts of the different proteins were incubated with the CK2 holoenzyme together with [g-32 P]ATP. Proteins were analysed on an SDS polyacrylamide gel and incorporated radioactivity was detected by autoradiography. As shown in Figure  3a (lane 1) wild-type cyclin H is strongly phosphorylated by CK2 whereas both point mutants of cyclin H were not phosphorylated at all. Figure 3b shows Coomassie blue stained protein bands for the corresponding wild-type or mutant cyclin H which were used as substrates. Thus, we have to conclude that threonine 315 is indeed the CK2 phosphorylation site.
In order to evaluate the functional consequence of the phosphorylation of cyclin H by CK2 we analysed the assembly and activity of the cyclin H/cdk7/Mat1 complex where cyclin H was substituted by either of the two phosphorylation mutants. The cyclin H mutant T315D mimics a permanent CK2 phosphorylation at position 315 whereas mutant T315A represents a nonphosphorylated form of cyclin H. We first controlled whether the point mutants might have an influence on the assembly of the cyclin H/cdk7/Mat1 complex. To produce cyclin H/cdk7/Mat1 kinase complexes we infected insect cells with recombinant baculoviruses expressing Mat1, cdk7 and cyclin H in either wild-type or one of the both mutated forms. Cyclin H/cdk7/ Mat1 complexes were immunoprecipitated from insect cells using GSH-sepharose to immobilize the GSTtagged form of Mat1. Protein complexes were separated on an SDS polyacrylamide gel and the gel was stained with Coomassie blue. As shown in Figure  4a for wild-type cyclin H as well as for the two cyclin H mutants we found trimeric cyclin H/cdk7/Mat1 complexes indicating that the point mutations at position 315 of cyclin H did not affect complex formation.
In the next experiment we analysed the kinase activity of the three different forms of cyclin H (cycH wt , cycH T315A or cycH T315D ) in complex with cdk7 and Mat1 (shown in Figure 4a ) with respect to the phosphorylation of the CTD peptide substrate. 
This peptide consists of 4 out of 28 repeats from the Cterminal domain (CTD) of the large subunit of RNA polymerase II. We found that the trimeric complex containing the T315A mutant of cyclin H showed a significantly reduced CTD phosphorylation activity compared to the kinase complex containing wild-type or the T315D mutant of cyclin H (Figure 4b ). The same results were obtained when the CTD peptide was exchanged by an alternative well established substrate for the cyclin H/cdk7/Mat1 kinase: namely the protein kinase cdk2 which was used in form of a GST fusion protein carrying a point mutation at position 33 (K?R) responsible for a loss of catalytic activity (Figure 5a) . The corresponding cyclin H/cdk7/Mat1 complexes used for the phosphorylation reactions are shown in Figure 5b . By repeating the experiment at least four times we always found a lower phosphorylation (60 -80%) of cdk2 in case of the cyclin H T315A / cdk7/Mat1 complex than for cyclin H wt /cdk7/Mat1 complex (set to 100%). These results led us to conclude that phosphorylation at threonine 315 by CK2 is essential for a full kinase activity of the cyclin H/cdk7/ Mat1 complex with respect to the phosphorylation of the CTD peptide derived from the C-terminal domain of RNA polymerase II as well as to cdk2.
Discussion
Cyclin dependent kinases are the main regulators of the eukaryotic cell cycle (Johnson and Walker, 1999) . They are composed of the regulatory subunits, the cyclins, and the catalytic subunits, called cdks. The cyclin H/ cdk7 complex normally contains a third subunit namely Mat1 which functions as an assembly factor stabilizing the kinase complex and as a factor which regulates the substrate specificity (Devault et al., 1995; Fisher et al., 1995; Tassan et al., 1995) . Cyclin dependent kinases are in general regulated by the assembly of the regulatory cyclin subunits with the catalytic cdk subunits, by phosphorylation and dephosphorylation of the cdks and by specific inhibitor molecules (for review see: Kaldis, 1999) . We recently identified p53 as a cyclin H binding protein and furthermore we could show that this interaction led to a down-regulation of the cyclin H/cdk7/Mat1 activity with regard to the phosphorylation of the C-terminal domain of the large subunit of RNA polymerase II and of the cdk2 kinase (Schneider et al., 1998) . Since mutant p53 His175 failed to down-regulate the cyclin H/ cdk7/Mat1 activity these data indicated that this kind of negative regulation of the kinase activity is exclusively due to a functional wild-type p53 (Schneider et al., 1998) .
Cyclins are also phosphoproteins and therefore potential targets for a regulation by phosphorylation and dephosphorylation. It was indeed recently shown that cyclin H was phosphorylated by the cyclin C/cdk8 kinase complex and this phosphorylation repressed both the ability of the cyclin H/cdk7/Mat1 kinase in the TFIIH complex to activate transcription and its CTD kinase activity (Akoulitchev et al., 2000) . In the present study we showed that cyclin H is also a substrate for another kinase namely protein kinase Using deletion mutants (data not shown) as well as point mutants we identified threonine 315 in the Cterminus of cyclin H as the main phosphorylation site for protein kinase CK2. These results were further confirmed by using synthetic peptides as a substrate for CK2. We found that only the peptide derived from position 311 -320 of authentic cyclin H including the potential phosphorylation site at threonine 315 was phosphorylated by CK2 (data not shown).
Most of the substrates for CK2 are only efficiently phosphorylated by the holoenzyme composed of two regulatory b-subunits and two catalytic a-or a'-subunits and only a few substrates are known to be better phosphorylated by the catalytic a-subunit alone (for review see: Guerra et al., 1999a) . Consistent with the majority of CK2 substrates we could show that cyclin H is more efficiently phosphorylated by the holoenzyme than by the catalytic a-subunit alone. This phosphorylation was efficiently reduced by heparin, a potent inhibitor of CK2.
Interestingly, the phosphorylation site at threonine 315 is in close vicinity of serine 304 which was shown to be phosphorylated by cyclin C/cdk8 (Akoulitchev et al., 2000) . There is an additional cyclin C/cdk8 phosphorylation site at serine 5 in the N-terminus of cyclin H. It was further shown that phosphorylation of cyclin H by cyclin C/cdk8 is critical for full kinase activity and transcriptional activity of the TFIIH associated cyclin H/cdk7/Mat1 kinase complex. The phosphorylation sites at Thr-315 and at Ser-304 are highly conserved in cyclin H homologues in human, rat, mice and Xenopus laevis (Labbe et al., 1994; Makela et al., 1994 ; gene bank accession number AAD46521). Thus, it was an intriguing question whether CK2 phosphorylation at position 315 might influence cyclin H/cdk7/Mat1 activity, too. By using wild-type cyclin H and the T315D and T315A mutants of cyclin H mimicking permanent phosphorylation or a non-phosphorylated form of cyclin H, respectively, we found a strong reduction in the cyclin H/cdk7/Mat1 kinase activity in the presence of the cyclin H T315A mutant. In contrast, in the presence of wild-type cyclin H or the cyclin H T315D mutant we found a strong phosphorylation of the CTD substrate peptide derived from the C-terminal domain of the large subunit of RNA polymerase II. Interestingly, phospho-specific antibodies which were raised against a short peptide spanning amino acids 311 -319 (EEEWT(P)DDDL) of cyclin H were able to recognize baculovirus expressed wild-type cyclin H. In contrast, these antibodies only detected bacterially expressed cyclin H after phosphorylation by CK2 (data not shown). Thus, wild-type cyclin H/cdk7/Mat1, which we used for the measurement of the CTD phosphorylation activity, represents at least in part cyclin H in a Thr-315 phosphorylated form.
When we used cdk2 instead of the CTD peptide as a substrate for the cyclin H/cdk7/Mat1 complex we obtained comparable results. Wild-type cyclin H in complex with cdk7 and Mat1 were able to efficiently phosphorylate cdk2. There was a slight but reproducible reduction in the kinase activity of the cyclin H/ cdk7/Mat1 complex carrying the cyclin H T315A mutant instead of wild-type cyclin H. In contrast, in the presence of the cyclin H T315D mutant we observed a strong phosphorylation of cdk2.
We have previously shown that the growth suppressor protein p53 plays a role as a direct inhibitor for the cyclin H/cdk7/Mat1 complex (Schneider et al., 1998) as well as for protein kinase CK2 (Schuster et al., 2001) . Inhibition of CK2 was specific for wild-type p53 and for the holoenzyme consisting of two catalytic a-and/ or a'-and two regulatory b-subunits. From a variety of different experiments there is ample evidence that CK2 is actively implicated in cell proliferation (for review see: Guerra and Issinger, 1999b; Pinna and Meggio, 1997) . Furthermore, it was shown previously that the carboxy-terminal heptapeptide of the largest subunit of RNA polymerase serves as an excellent substrate for purified CK2 (Angiolillo et al., 1993) and also for cyclin C/cdk8 (Akoulitchev et al., 2000) . Thus, CK2 can directly regulate RNA polymerase II by phosphorylation and indirectly by the activating phosphorylation of the cyclin H/cdk7/Mat1 kinase complex. The present data together with previous results led to the following hypothesis. Up-regulation of p53 in a cell due to various stress situations can result in two effects with respect to the activity of the cyclin H/cdk7/Mat1 complex. First, p53 inhibits the cyclin H/cdk7/Mat1 activity directly by binding to cyclin H. Second, p53 inhibits the activity of the CK2 holoenzyme thus preventing the stimulating phosphorylation of cyclin H, which is necessary for its full activity. Both effects lead to a down-regulation of the RNA polymerase II dependent transcription as well as to cell cycle arrest.
Materials and methods

Plasmids and recombinant baculoviruses
cDNAs of cyclin H, cdk7 and Mat1 were isolated by PCR from HeLa and human testis cDNA libraries and verified by sequencing. All newly constructed plasmids used herein were subcloned from vectors already described (Schneider et al., 1998) . For the bacterial expression of wild-type cyclin H we used the pQE30 vector (Qiagen) (Schneider et al., 1998) . For baculovirus expression cdk7 full length cDNA (Schneider et al., 1998) , wild type and point mutants of cyclin H cDNA were cloned as PstI/HindIII or BamHI/HindIII fragments, respectively, into pBacPAK-His1 thus also allowing the purification by the N-terminal histidine tag. Mat1 was cloned as GST fusion construct into pAcG1 (Pharmingen, San Diego, CA, USA). In an overlap extension PCR procedure the mutations ACT to GCA and ACT to GAC of codon 315 resulting in an exchange of threonine 315 to alanine or aspartic acid, respectively, were introduced by primer directed mutagenesis. Subsequently, mutants were also cloned into pBacPAK-His1. All constructs were verified by sequencing.
Expression and purification of proteins produced in Sf9 cells
Sf9 (Spodoptera frugiperda) cells were grown in Sf900 medium (Gibco, Life Technologies) with 10% foetal calf serum (FCS) at 278C. For the construction of baculoviruses CK2 phosphorylation of cyclin H E Schneider et al expressing human proteins the coding cDNAs were cloned into baculo transfer vectors (pBacPAK -constructs, pacG1 -Mat1) and then transferred into baculovirus DNA by recombination with Baculogold-DNA as recommended by the manufacturer (Pharmingen). The resulting viruses were used to infect Sf9 cells and to express the protein. Insect cells were triple infected with recombinant viruses expressing cdk7, Mat1, and cyclin H either in its wild-type or mutant form. Forty-eight hours after infection cells were harvested by centrifugation, washed twice with ice-cold PBS and then lysed in either a hypotonic buffer (20 mM NaH 2 PO 4, pH 8.0, 20 mM NaCl, 0.5 mM DTT, protease inhibitors (complete TM , Roche Mannheim) for purification by the His tag) or in a HEPES -buffered solution (10 mM HEPES pH 7.4, 10 mM NaCl, 1 mM EDTA, 1 mM DTT for purification by the GST tag). For purification by the GST tag cells were lysed at 48C, sonicated and cleared by centrifugation. The supernatant was mixed with the glutathion Sepharose (Amersham -Pharmacia) and binding of the GST fusion protein was allowed to take place for 2 h at 48C. The resin was washed with phosphate buffered saline (PBS). Elution of trimeric cyclin H/ cdk7/Mat1 complex or monomeric subunits was achieved by elution with 50 mM Tris/HCl pH 8.0, 5 mM MgCl 2 , 150 mM NaCl, 1 mM DTT, 5 mM glutathion. For the purification of His tagged proteins expressing cells were extracted for 15 min on ice. The extracts were sonicated and cleared by centrifugation. The supernatant was diluted with 1/30 volume 1 M phosphate buffer, pH 8.0 and 2/5 volume 1 M KCl and subsequently incubated with Ni 2+ -NTA agarose (Qiagen) for 1 h on ice. The resin was washed with 20 mM Tris/HCl, pH 8.0, 300 mM KCl, 10 mM MgCl 2, 0.1% Tween 20 and 20 mM imidazole. Proteins were eluted from the resin by increasing the imidazole concentration stepwise between 50 and 100 mM.
In vitro phosphorylation assays
Recombinant protein kinase CK2 was expressed and purified as described earlier (Appel et al., 1995) . Recombinant cyclin H proteins (0.5 mg) from baculovirus infected insect cells were mixed with recombinant protein kinase CK2 in 20 ml kinase buffer (50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 5 mM MgCl 2 , 1 mM DTT) essentially as described (Go¨tz et al., 1996) . The phosphorylation reaction was started by the addition of 1 mCi [g-32 P]ATP. After 30 min at 378C the reaction was stopped by addition of 10 ml SDS loading buffer (130 mM Tris/HCl, pH 6.8, 0.02% bromophenolblue, 10 mM 2-mercaptoethanol, 20% glycerin, 4% SDS) and boiling. Phosphorylated proteins were separated in a 12.5% SDS polyacrylamide gel and subsequently visualized by autoradiography. Cyclin H/cdk7/Mat1 complexes were produced in Sf9 cells and purified by the GST tag of Mat1 or the His-tag of cyclin H as described above. As substrate served 5 mm of a synthetic peptide comprising four times the hepta repeats (YSPTSPS) of the C-terminal domain of the large subunit of human RNA polymerase II or GST-cdk2 K33R . Kinase reactions were performed in 20 mM Tris/HCl, pH 7.8, 100 mM KCl, 10 mM MgCl 2 , 0.1% Tween20, 1 mM ATP (unlabelled), 1 mCi [g-32 P]ATP using 1 pmole purified trimeric cyclin H/cdk7/Mat1. The kinase reaction was started by the addition of ATP (labelled and unlabelled) and incubated for 30 min at 378C. After stopping the reaction with SDS loading buffer the reaction mixture was analysed by SDS polyacrylamide gel electrophoresis. Phosphorylation of the CTD peptide or cdk2 K33R was visualized by autoradiography.
SDS polyacrylamide gel electrophoresis and Western blot analysis
Proteins were analysed by SDS gel electrophoresis according to the procedure of Laemmli (1970) . For Western blot analysis proteins were transferred to a PVDF membrane by tank blotting with 20 mM Tris/HCl, pH 8.7, 150 mM glycine as transfer buffer. Membranes were blocked in PBS with 0.1% Tween20 and 5% dry milk for 1 h at room temperature. The membrane was incubated with the primary antibody in PBS-Tween 20 with 1% dry milk for another hour. The membrane was then washed with PBS-Tween20 three times before incubating with a peroxidase-coupled secondary antibody in a dilution of 1 : 30 000 in PBS Tween 20 with 1% dry milk. Signals were developed and visualized by the Lumilight system of Roche Diagnostics (Mannheim, Germany).
